Seraphina Therapeutics, Inc.

Seraphina Therapeutics, Inc. is a pioneering health and wellness company dedicated to advancing global health through the discovery, development, and commercialization of essential fatty acids and evidence-driven consumer health products. Founded by a team of accomplished scientists, physicians, and entrepreneurs, Seraphina Therapeutics is at the forefront of nutritional science, focusing on the identification and application of key micronutrients and metabolites that support healthier lives, particularly as people age.\n\nThe company’s flagship innovation centers on C15:0, also known as pentadecanoic acid, a trace odd-chain saturated fatty acid found in butter, whole milk, and certain fish and plants. Seraphina Therapeutics has been instrumental in bringing global scientific attention to C15:0, which is now recognized as the first essential fatty acid to be discovered in 90 years. The company’s research and advocacy have positioned C15:0 alongside omega-3 and omega-6 as a critical nutrient for human health.\n\nSeraphina Therapeutics advances nature and food-based science into consumer products that replenish vital nutrients. Their approach is rooted in rigorous scientific research, with over 70 peer-reviewed publications and more than 40 patents attributed to their leadership team. The company’s founders include Dr. Stephanie Venn-Watson, a veterinary epidemiologist and public health scientist with extensive experience at the Centers for Disease Control and Prevention and the World Health Organization; Dr. Eric Venn-Watson, a practicing physician and entrepreneur with a background in healthcare analytics and medical device innovation; Dr. Kim Kamdar, a venture capitalist and former research director at Novartis; Dr. Nicholas Schork, a leader in longevity research; Dr. Edward Dennis, a renowned lipid researcher; and Dr. Ronald Krauss, a senior scientist specializing in atherosclerosis and nutrition.\n\nSeraphina Therapeutics’ primary product line is centered around C15:0, marketed under the brand name fatty15. Fatty15 is a science-backed supplement designed to restore and maintain healthy levels of C15:0, supporting cellular health, metabolic function, and overall well-being. The company’s products are developed with a commitment to safety, efficacy, and transparency, leveraging the latest advances in lipidomics, metabolomics, and nutritional biochemistry.\n\nThe company serves a broad range of industries, including consumer packaged goods (CPG), dietary supplements, functional foods, and health and wellness. Their products are distributed through direct-to-consumer channels, online marketplaces, and select retail partners. Seraphina Therapeutics collaborates with leading research institutions, healthcare providers, and industry partners to advance the science of essential fatty acids and promote public health.\n\nNotable clients and partners include academic institutions, healthcare organizations, and wellness brands that share Seraphina’s commitment to evidence-based nutrition. The company’s scientific advisory board features distinguished experts in chemistry, biochemistry, pharmacology, and nutrition, ensuring that all products and initiatives are grounded in the highest standards of research and clinical validation.\n\nSeraphina Therapeutics is headquartered in the United States and operates with a global perspective, aiming to impact health outcomes worldwide. The company’s mission is to empower individuals to take control of their health through scientifically validated nutrition, with a focus on longevity, disease prevention, and optimal aging.\n\nIn addition to product development, Seraphina Therapeutics is actively involved in public education, advocacy, and policy initiatives related to essential fatty acids and nutritional health. The company regularly publishes research findings, participates in industry conferences, and engages with the scientific community to advance the understanding of C15:0 and its role in human health.\n\nThrough its innovative products, research-driven approach, and commitment to public health, Seraphina Therapeutics, Inc. is redefining the landscape of nutritional science and consumer health, offering new solutions for healthy aging and disease prevention.